semaglutide 1.25 mg dose (Ozempic) for Type 2 Diabetes Mellitus Semaglutide Weight Loss Dosage Chart

However, they need further evidence-based studies

Weight loss parity with AOM augmentation Clinical evidence demonstrates that early non-responders to behavioral therapy can achieve comparable weight outcomes to initial strong responders when provided with anti-obesity medication (AOM)

What side effects should we watch for

Do not make assumptions about safety Exceeded in-use storage period Discard the pen according to local waste disposal guidelines for sharps and medications Clinical implications of using degraded medication may include inadequate glycaemic control in diabetes management or reduced weight loss efficacy

Some patients may require long-term use to maintain their results